 |
 |
|
|---|---|---|
| COMPOSITION | HYALURONIC ACID | HYALURONIC ACID + GLUCOSAMINE |
| HA CONTENT | 120 MG PER CAPSULE | 120 MG PER 3 CAPSULES |
| GLUCOSAMINE CONTENT | NONE | 1500 MG PER 3 CAPSULES |
| HA MOLECULAR WEIGHT | 1 MILLION DALTON | |
| INDICATION | TREATMENT OF OSTEOARTHRITIS | |
| EFFECTS | PAIN RELIEF, MOBILITY IMPROVEMENT, CARTILAGE PROTECTION | |
| ADMINISTRATION | ORAL | |
| DOSAGE | 1 CAPSULE DAILY | 3 CAPSULES DAILY |
| ONSET OF EFFECTS | A COUPLE OF WEEKS OF REGULAR INTAKE | |
| DURATION OF EFFECTS | UP TO 3 MONTHS AFTER THE LAST INTAKE | |
| PACKAGING | BOTTLE OF 120 CAPSULES | |
| STORAGE | AT ROOM TEMPERATURE IN A DRY ENVIRONMENT | |
VISCALGIC® and VISCALGIC® GS are composed of pharmaceutical-grade ingredients of non-animal origin manufactured through a biofermentation process. As a result, VISCALGIC® and VISCALGIC® GS have a high purity, an improved biological activity and are free from animal proteins potentially responsible for allergenic reactions as well as from transmissible infectious agents (viruses and prions). VISCALGIC® and VISCALGIC® GS are suitable for halal, kosher, vegan and vegetarian diets. VISCALGIC® and VISCALGIC® GS are CE-marked medical device products with safety and efficacy assessed under European Medical Device Directive 93/42/EEC.